Bibliografia

Principal

  • xxxx (xxxx) • Relevant scientific papers, regulatory documents and guidelines (provided by the professor)
  • Tiligada E, Ishii M, Riccardi C, Spedding M, Simon HU, Teixeira MM, Cuervo ML, Holgate ST, Levi-Schaffer F. (2015) The expanding role of immunopharmacology: IUPHAR Review 16. Br J Pharmacol. 2015;172(17):4217-27.
  • • DiDonato JA, Mercurio F, Karin M. (2012) NF-κB and the link between inflammation and cancer. Immunol Rev. 2012. 246(1):379-400.
  • Cohen A. (2006) From pharmacology to immunopharmacology. Br J Clin Pharmacol. 2006. 62(4):379-82.
  • Caux C, Zitvogel L. (2012) Recent successes of cancer immunotherapy: a new dimension in personalized medicine? Target Oncol. 2012. 7(1):1-2
  • R.C. Rees (ed.) (2014) Tumor Immunology and Immunotherapy 1st Edition, Oxford University Press, 2014.
  • G.C. Prendergast, E.M. Jaffee (eds.), (2013) Cancer Immunotherapy: Immune Suppression and Tumor Growth 2nd Edition, Academic Press, 2013.
  • Yoshiyuki Yamaguchi (ed.) (2016) Immunotherapy of Cancer: An Innovative Treatment Comes of Age, 1st Edition, Springer, 2016
  • F.D. Nijkamp & M.J. Parnham (eds.), Springer-Verlag (2011) Principles of Immunopharmacology, 3rd Edition 3rd Edition,
  • Manzoor M Khan (2018) Immunopharmacology. 2nd edition 2018 Springer International Publishing. https://doi.org/10.1007/978-3-319-30273-7
  • By Carlo Riccardi (Editor), Francesca Levi-Schaffer (Editor), Ekaterini Tiligada (Editor) (2019) • Immunopharmacology and Inflammation 1st ed. 2019 Springer International Publishing
  • By Cheryl Rockwell (Editor), Bryan Copple (Editor). Academic Press (2021) Advances in Immunopharmacology. Academic Press; 1st edition (5 Jun. 2021)

Secundária

Não foi definida bibliografia secundária